As the first discovered YAP/TAZ fusion protein, TAZ::CAMTA1 was quickly shown to drive transformation and anchorage-independent growth in 3T3 fibroblast cells, MS1 endothelial cells, and SW872 liposarcoma cells (Driskill et al. 2021, Merritt et al. 2021, Tanas et al. 2016). Here, TAFAZZIN is linked to liposarcoma.